- US12565538utility2026Fcrn/antigen-binding Molecules and Methods of Use0 cites
- US12403175utility2025Methods for Treating Pemphigus Disorders0 cites
- US12344678utility2025Fcrn/hsa Binding Molecules and Methods of Use0 cites
- US12240875utility2025Use of FCRN Antagonists for Treatment of Generalized Myasthenia Gravis0 cites
- US12202900utility2025Compositions and Methods for Treating Immune Thrombocytopenia0 cites
- US12180293utility2024CD70 Combination Therapy0 cites
- US12071486utility2024Bispecific Antigen Binding Construct0 cites
- US12060413utility2024Method of Preparing Ph-dependent Antibodies0 cites
- US12030949utility2024Multispecific Antibodies Against IL-5 and IL-4R0 cites
- US11827701utility2023IL-6 Binding Molecules0 cites
- US11708403utility2023Antibodies to Human Complement Factor C2B and Methods of Use0 cites
- US11649295utility2023Asymmetric Multispecific Antibodies0 cites
- US11591386utility2023Antibodies to Human Complement C2B0 cites
- US11591388utility2023Pharmaceutical Formulations of Fcrn Inhibitors Suitable for Subcutaneous Administration0 cites